Interaction Checker

Trinitrine : interactions médicamenteuses

Trinitrine (Nitrostat, Nitro-Dur, Nitrolingual), dérivé nitré, présente 131 interactions documentées dans les notices FDA et les fiches d'information que nous indexons : 13 de niveau majeur, 111 de niveau modéré, 7 de niveau mineur et 0 cas où une notice ne signale aucune interaction significative. Chaque entrée ci-dessous cite la phrase sur laquelle elle repose. Cette page consacrée à un médicament est un point de départ, pas un verdict sur votre situation.

Interactions d'après la notice

Interactions majeures (13)

  • Avanafilinhibiteur de la PDE5Majeure

    Use of phosphodiesterase type 5 (PDE-5) Inhibitors, such as avanafil, sildenafil, tadalafil, or vardenafil, or soluble guanylate cyclase (sGC) stimulator (riociguat). (notice Trinitrine, Contre-indications)

  • Bromocriptineagoniste de la dopamineMajeure

    Therefore, patients receiving sublingual nitroglycerin should avoid ergotamine and related drugs or be monitored for symptoms of ergotism if this is not possible. (notice Trinitrine, Interactions médicamenteuses)

  • Cabergolineagoniste de la dopamineMajeure

    Therefore, patients receiving sublingual nitroglycerin should avoid ergotamine and related drugs or be monitored for symptoms of ergotism if this is not possible. (notice Trinitrine, Interactions médicamenteuses)

  • Dihydroergotaminealcaloïde de l'ergot de seigleMajeure

    Therefore, patients receiving sublingual nitroglycerin should avoid ergotamine and related drugs or be monitored for symptoms of ergotism if this is not possible. (notice Trinitrine, Interactions médicamenteuses)

  • Dinitrate d'isosorbidedérivé nitréMajeure

    Hypersensitivity to Nitroglycerin Lingual Spray or to other nitrates or nitrites or any excipient. (notice Trinitrine, Contre-indications)

  • Dinitrate d'isosorbide et hydralazinedérivé nitréMajeure

    Hypersensitivity to Nitroglycerin Lingual Spray or to other nitrates or nitrites or any excipient. (notice Trinitrine, Contre-indications)

  • Ergotamine et caféinealcaloïde de l'ergot de seigleMajeure

    Therefore, patients receiving sublingual nitroglycerin should avoid ergotamine and related drugs or be monitored for symptoms of ergotism if this is not possible. (notice Trinitrine, Interactions médicamenteuses)

  • Méthylergométrinealcaloïde de l'ergot de seigleMajeure

    Therefore, patients receiving sublingual nitroglycerin should avoid ergotamine and related drugs or be monitored for symptoms of ergotism if this is not possible. (notice Trinitrine, Interactions médicamenteuses)

  • Mononitrate d'isosorbidedérivé nitréMajeure

    Hypersensitivity to Nitroglycerin Lingual Spray or to other nitrates or nitrites or any excipient. (notice Trinitrine, Contre-indications)

  • RiociguatvasodilatateurMajeure

    Use of phosphodiesterase type 5 (PDE-5) Inhibitors, such as avanafil, sildenafil, tadalafil, or vardenafil, or soluble guanylate cyclase (sGC) stimulator (riociguat). (notice Trinitrine, Contre-indications)

  • Sildénafilinhibiteur de la PDE5Majeure

    Use of phosphodiesterase type 5 (PDE-5) Inhibitors, such as avanafil, sildenafil, tadalafil, or vardenafil, or soluble guanylate cyclase (sGC) stimulator (riociguat). (notice Trinitrine, Contre-indications)

  • Tadalafilinhibiteur de la PDE5Majeure

    Use of phosphodiesterase type 5 (PDE-5) Inhibitors, such as avanafil, sildenafil, tadalafil, or vardenafil, or soluble guanylate cyclase (sGC) stimulator (riociguat). (notice Trinitrine, Contre-indications)

  • Vardénafilinhibiteur de la PDE5Majeure

    Use of phosphodiesterase type 5 (PDE-5) Inhibitors, such as avanafil, sildenafil, tadalafil, or vardenafil, or soluble guanylate cyclase (sGC) stimulator (riociguat). (notice Trinitrine, Contre-indications)

Interactions modérées (111)

  • AcébutololbêtabloquantModérée

    Antihypertensives: Possible additive hypotensive effects. (notice Trinitrine, Interactions médicamenteuses)

  • Acide étacryniquediurétique de l'anseModérée

    Antihypertensives: Possible additive hypotensive effects. (notice Trinitrine, Interactions médicamenteuses)

  • AdénosineantiarythmiqueModérée

    Hypotension Adenosine injection is a potent peripheral vasodilator and can induce significant hypotension. (notice Adénosine, Mises en garde et précautions)

  • AlfuzosinealphabloquantModérée

    Postural hypotension/syncope: Care should be taken in patients with symptomatic hypotension or who have had a hypotensive response to other medications or are concomitantly treated with antihypertensive medication or nitrates ( 5.1 ) (notice Alfuzosine, Mises en garde et précautions)

  • AliskirèneantihypertenseurModérée

    Antihypertensives: Possible additive hypotensive effects. (notice Trinitrine, Interactions médicamenteuses)

  • Amiloridediurétique épargneur de potassiumModérée

    Antihypertensives: Possible additive hypotensive effects. (notice Trinitrine, Interactions médicamenteuses)

  • Amlodipineinhibiteur calcique dihydropyridiniqueModérée

    Antihypertensives: Possible additive hypotensive effects. (notice Trinitrine, Interactions médicamenteuses)

  • Amlodipine et atorvastatineinhibiteur calcique dihydropyridiniqueModérée

    Antihypertensives: Possible additive hypotensive effects. (notice Trinitrine, Interactions médicamenteuses)

  • Amlodipine et bénazéprilinhibiteur calcique dihydropyridiniqueModérée

    Antihypertensives: Possible additive hypotensive effects. (notice Trinitrine, Interactions médicamenteuses)

  • Amlodipine et olmésartaninhibiteur calcique dihydropyridiniqueModérée

    Antihypertensives: Possible additive hypotensive effects. (notice Trinitrine, Interactions médicamenteuses)

  • Amlodipine et valsartaninhibiteur calcique dihydropyridiniqueModérée

    Antihypertensives: Possible additive hypotensive effects. (notice Trinitrine, Interactions médicamenteuses)

  • Articaïne et adrénalineanesthésique localModérée

    Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics… (notice Articaïne et adrénaline, Interactions médicamenteuses)

  • AténololbêtabloquantModérée

    Antihypertensives: Possible additive hypotensive effects. (notice Trinitrine, Interactions médicamenteuses)

  • Aténolol et chlortalidonebêtabloquantModérée

    Antihypertensives: Possible additive hypotensive effects. (notice Trinitrine, Interactions médicamenteuses)

  • Azilsartanantagoniste des récepteurs de l'angiotensine II (ARA II)Modérée

    Antihypertensives: Possible additive hypotensive effects. (notice Trinitrine, Interactions médicamenteuses)

  • Bénazéprilinhibiteur de l'enzyme de conversion (IEC)Modérée

    Antihypertensives: Possible additive hypotensive effects. (notice Trinitrine, Interactions médicamenteuses)

  • Bénazépril et hydrochlorothiazideinhibiteur de l'enzyme de conversion (IEC)Modérée

    Antihypertensives: Possible additive hypotensive effects. (notice Trinitrine, Interactions médicamenteuses)

  • BétaxololbêtabloquantModérée

    Antihypertensives: Possible additive hypotensive effects. (notice Trinitrine, Interactions médicamenteuses)

  • BisoprololbêtabloquantModérée

    Antihypertensives: Possible additive hypotensive effects. (notice Trinitrine, Interactions médicamenteuses)

  • Bisoprolol et hydrochlorothiazidebêtabloquantModérée

    Antihypertensives: Possible additive hypotensive effects. (notice Trinitrine, Interactions médicamenteuses)

  • Brimonidine et timololagoniste alpha-adrénergiqueModérée

    Antihypertensives Patients receiving antihypertensive drugs, beta-adrenergic blockers, and nitrates should be observed for possible additive hypotensive effects. (notice Trinitrine, Interactions médicamenteuses)

  • Bupivacaïneanesthésique localModérée

    • Drugs Associated with Methemoglobinemia : Patients are at increased risk of developing methemoglobinemia when concurrently exposed to nitrates, nitrites, local anesthetics, antineoplastic agents, antibiotics, antimalarials, anticonvulsants, and other drugs. (notice Bupivacaïne, Interactions médicamenteuses)

  • Bupivacaïne et adrénalineanesthésique localModérée

    Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics… (notice Bupivacaïne et adrénaline, Interactions médicamenteuses)

  • Candésartanantagoniste des récepteurs de l'angiotensine II (ARA II)Modérée

    Antihypertensives: Possible additive hypotensive effects. (notice Trinitrine, Interactions médicamenteuses)

  • Candésartan et hydrochlorothiazideantagoniste des récepteurs de l'angiotensine II (ARA II)Modérée

    Antihypertensives: Possible additive hypotensive effects. (notice Trinitrine, Interactions médicamenteuses)

  • Captoprilinhibiteur de l'enzyme de conversion (IEC)Modérée

    Antihypertensives: Possible additive hypotensive effects. (notice Trinitrine, Interactions médicamenteuses)

  • CarvédilolbêtabloquantModérée

    Antihypertensives: Possible additive hypotensive effects. (notice Trinitrine, Interactions médicamenteuses)

  • Chloroprocaïneanesthésique localModérée

    …concurrently exposed to the following drugs, which could include other local anesthetics: Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic… (notice Chloroprocaïne, Précautions)

  • Chlorothiazidediurétique thiazidiqueModérée

    Antihypertensives: Possible additive hypotensive effects. (notice Trinitrine, Interactions médicamenteuses)

  • Chlortalidonediurétique thiazidiqueModérée

    Antihypertensives: Possible additive hypotensive effects. (notice Trinitrine, Interactions médicamenteuses)

  • Clonidineagoniste alpha-adrénergiqueModérée

    Antihypertensives: Possible additive hypotensive effects. (notice Trinitrine, Interactions médicamenteuses)

  • Dexmédétomidineagoniste alpha-adrénergiqueModérée

    • Co-administration with Other Vasodilators or Negative Chronotropic Agents : Use with caution due to additive pharmacodynamic effects. (notice Dexmédétomidine, Mises en garde et précautions)

  • DicyclovérineanticholinergiqueModérée

    …drugs including dicyclomine hydrochloride: amantadine, antiarrhythmic agents of Class I (e.g., quinidine), antihistamines, antipsychotic agents (e.g., phenothiazines), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., meperidine), nitrates and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity. (notice Dicyclovérine, Interactions médicamenteuses)

  • Diltiazeminhibiteur calciqueModérée

    Antihypertensives: Possible additive hypotensive effects. (notice Trinitrine, Interactions médicamenteuses)

  • DofétilideantiarythmiqueModérée

    …oral anticoagulants, calcium channel blockers, beta blockers, cardiac glycosides, inducers of CYP3A4, substrates and inhibitors of CYP3A4, substrates and inhibitors of P-glycoprotein, nitrates, sulphonylureas, loop diuretics, potassium sparing diuretics, thiazide diuretics, substrates and inhibitors of tubular organic cation transport, and QTc-prolonging drugs. (notice Dofétilide, Interactions médicamenteuses)

  • Dorzolamide et timololinhibiteur de l'anhydrase carboniqueModérée

    Antihypertensives Patients receiving antihypertensive drugs, beta-adrenergic blockers, and nitrates should be observed for possible additive hypotensive effects. (notice Trinitrine, Interactions médicamenteuses)

  • DoxazosinealphabloquantModérée

    Antihypertensives: Possible additive hypotensive effects. (notice Trinitrine, Interactions médicamenteuses)

  • Éconazoleantifongique azoléModérée

    Most cases reported product application with use under occlusion, genital application, or application to a large body surface area which may increase the systemic absorption of econazole nitrate. (notice Éconazole, Interactions médicamenteuses)

  • Énalaprilinhibiteur de l'enzyme de conversion (IEC)Modérée

    Antihypertensives: Possible additive hypotensive effects. (notice Trinitrine, Interactions médicamenteuses)

  • Énalapril et hydrochlorothiazideinhibiteur de l'enzyme de conversion (IEC)Modérée

    Antihypertensives: Possible additive hypotensive effects. (notice Trinitrine, Interactions médicamenteuses)

  • Énalaprilateinhibiteur de l'enzyme de conversion (IEC)Modérée

    Antihypertensives: Possible additive hypotensive effects. (notice Trinitrine, Interactions médicamenteuses)

  • Éplérénoneantagoniste de l'aldostéroneModérée

    Antihypertensives: Possible additive hypotensive effects. (notice Trinitrine, Interactions médicamenteuses)

  • Époprosténolanalogue de prostaglandineModérée

    Additional reductions in blood pressure may occur when VELETRI is administered with diuretics, antihypertensive agents, or other vasodilators. (notice Époprosténol, Interactions médicamenteuses)

  • EsmololbêtabloquantModérée

    Antihypertensives Patients receiving antihypertensive drugs, beta-adrenergic blockers, and nitrates should be observed for possible additive hypotensive effects. (notice Trinitrine, Interactions médicamenteuses)

  • Étonogestrel et éthinylestradiolestrogèneModérée

    Co-administration of vaginal miconazole nitrate and Etonogestrel/Ethinyl Estradiol Vaginal Ring increases the serum concentrations of etonogestrel and ethinyl estradiol by up to 40% [see Clinical Pharmacology (12.3) ] . (notice Étonogestrel et éthinylestradiol, Interactions médicamenteuses)

  • Félodipineinhibiteur calcique dihydropyridiniqueModérée

    Antihypertensives: Possible additive hypotensive effects. (notice Trinitrine, Interactions médicamenteuses)

  • Fosinoprilinhibiteur de l'enzyme de conversion (IEC)Modérée

    Antihypertensives: Possible additive hypotensive effects. (notice Trinitrine, Interactions médicamenteuses)

  • Fosinopril et hydrochlorothiazideinhibiteur de l'enzyme de conversion (IEC)Modérée

    Antihypertensives: Possible additive hypotensive effects. (notice Trinitrine, Interactions médicamenteuses)

  • Furosémidediurétique de l'anseModérée

    Antihypertensives: Possible additive hypotensive effects. (notice Trinitrine, Interactions médicamenteuses)

  • Guanfacineagoniste alpha-adrénergiqueModérée

    Antihypertensives: Possible additive hypotensive effects. (notice Trinitrine, Interactions médicamenteuses)

  • HéparineanticoagulantModérée

    Intravenous nitroglycerin administered to heparinized patients may result in a decrease of the partial thromboplastin time with subsequent rebound effect upon discontinuation of nitroglycerin. (notice Héparine, Interactions médicamenteuses)

  • HydralazinevasodilatateurModérée

    Antihypertensives: Possible additive hypotensive effects. (notice Trinitrine, Interactions médicamenteuses)

  • Hydrochlorothiazidediurétique thiazidiqueModérée

    Antihypertensives: Possible additive hypotensive effects. (notice Trinitrine, Interactions médicamenteuses)

  • Indapamidediurétique thiazidiqueModérée

    Antihypertensives: Possible additive hypotensive effects. (notice Trinitrine, Interactions médicamenteuses)

  • Irbésartanantagoniste des récepteurs de l'angiotensine II (ARA II)Modérée

    Antihypertensives: Possible additive hypotensive effects. (notice Trinitrine, Interactions médicamenteuses)

  • Irbésartan et hydrochlorothiazideantagoniste des récepteurs de l'angiotensine II (ARA II)Modérée

    Antihypertensives: Possible additive hypotensive effects. (notice Trinitrine, Interactions médicamenteuses)

  • Isradipineinhibiteur calcique dihydropyridiniqueModérée

    Antihypertensives: Possible additive hypotensive effects. (notice Trinitrine, Interactions médicamenteuses)

  • LabétalolbêtabloquantModérée

    Antihypertensives: Possible additive hypotensive effects. (notice Trinitrine, Interactions médicamenteuses)

  • Lidocaïne et adrénalineanesthésique localModérée

    Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, isofamide, rasburicase Antibiotics… (notice Lidocaïne et adrénaline, Interactions médicamenteuses)

  • Lidocaïne et prilocaïneanesthésique localModérée

    …concurrently exposed to the following drugs, which could include other local anesthetics: Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic… (notice Lidocaïne et prilocaïne, Interactions médicamenteuses)

  • Lisinoprilinhibiteur de l'enzyme de conversion (IEC)Modérée

    Antihypertensives: Possible additive hypotensive effects. (notice Trinitrine, Interactions médicamenteuses)

  • Lisinopril et hydrochlorothiazideinhibiteur de l'enzyme de conversion (IEC)Modérée

    Antihypertensives: Possible additive hypotensive effects. (notice Trinitrine, Interactions médicamenteuses)

  • Lofexidineagoniste alpha-adrénergiqueModérée

    Antihypertensives: Possible additive hypotensive effects. (notice Trinitrine, Interactions médicamenteuses)

  • Losartanantagoniste des récepteurs de l'angiotensine II (ARA II)Modérée

    Antihypertensives: Possible additive hypotensive effects. (notice Trinitrine, Interactions médicamenteuses)

  • Losartan et hydrochlorothiazideantagoniste des récepteurs de l'angiotensine II (ARA II)Modérée

    Antihypertensives: Possible additive hypotensive effects. (notice Trinitrine, Interactions médicamenteuses)

  • MécamylamineantihypertenseurModérée

    Antihypertensives: Possible additive hypotensive effects. (notice Trinitrine, Interactions médicamenteuses)

  • Mépivacaïneanesthésique localModérée

    …when concurrently exposed to the following drugs, which could include other local anesthetics: Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitroglycerin, nitroprusside, nitric oxide, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine… (notice Mépivacaïne, Interactions médicamenteuses)

  • MéthyldopaantihypertenseurModérée

    Antihypertensives: Possible additive hypotensive effects. (notice Trinitrine, Interactions médicamenteuses)

  • Métolazonediurétique thiazidiqueModérée

    Antihypertensives: Possible additive hypotensive effects. (notice Trinitrine, Interactions médicamenteuses)

  • MétoprololbêtabloquantModérée

    Antihypertensives: Possible additive hypotensive effects. (notice Trinitrine, Interactions médicamenteuses)

  • Métoprolol et hydrochlorothiazidebêtabloquantModérée

    Antihypertensives: Possible additive hypotensive effects. (notice Trinitrine, Interactions médicamenteuses)

  • MinoxidilvasodilatateurModérée

    Antihypertensives: Possible additive hypotensive effects. (notice Trinitrine, Interactions médicamenteuses)

  • Moexiprilinhibiteur de l'enzyme de conversion (IEC)Modérée

    Antihypertensives: Possible additive hypotensive effects. (notice Trinitrine, Interactions médicamenteuses)

  • NadololbêtabloquantModérée

    Antihypertensives: Possible additive hypotensive effects. (notice Trinitrine, Interactions médicamenteuses)

  • NébivololbêtabloquantModérée

    Antihypertensives: Possible additive hypotensive effects. (notice Trinitrine, Interactions médicamenteuses)

  • NiacineModérée

    Caution should also be used when niacin extended-release tablets are used in patients with unstable angina or in the acute phase of an MI, particularly when such patients are also receiving vasoactive drugs such as nitrates, calcium channel blockers, or adrenergic blocking agents. (notice Niacine, Mises en garde et précautions)

  • Nicardipineinhibiteur calcique dihydropyridiniqueModérée

    Antihypertensives: Possible additive hypotensive effects. (notice Trinitrine, Interactions médicamenteuses)

  • Nifédipineinhibiteur calcique dihydropyridiniqueModérée

    Antihypertensives: Possible additive hypotensive effects. (notice Trinitrine, Interactions médicamenteuses)

  • Nimodipineinhibiteur calcique dihydropyridiniqueModérée

    Marked orthostatic hypotension has been reported when calcium channel blockers and organic nitrates were used concomitantly. (notice Trinitrine, Interactions médicamenteuses)

  • Nisoldipineinhibiteur calcique dihydropyridiniqueModérée

    Antihypertensives: Possible additive hypotensive effects. (notice Trinitrine, Interactions médicamenteuses)

  • Nitroprussiate de sodiumvasodilatateurModérée

    Antihypertensives: Possible additive hypotensive effects. (notice Trinitrine, Interactions médicamenteuses)

  • Olmésartanantagoniste des récepteurs de l'angiotensine II (ARA II)Modérée

    Antihypertensives: Possible additive hypotensive effects. (notice Trinitrine, Interactions médicamenteuses)

  • Olmésartan et hydrochlorothiazideantagoniste des récepteurs de l'angiotensine II (ARA II)Modérée

    Antihypertensives: Possible additive hypotensive effects. (notice Trinitrine, Interactions médicamenteuses)

  • Olmésartan, amlodipine et hydrochlorothiazideantagoniste des récepteurs de l'angiotensine II (ARA II)Modérée

    Antihypertensives: Possible additive hypotensive effects. (notice Trinitrine, Interactions médicamenteuses)

  • Périndoprilinhibiteur de l'enzyme de conversion (IEC)Modérée

    Antihypertensives: Possible additive hypotensive effects. (notice Trinitrine, Interactions médicamenteuses)

  • PhénoxybenzaminealphabloquantModérée

    Antihypertensives: Possible additive hypotensive effects. (notice Trinitrine, Interactions médicamenteuses)

  • PindololbêtabloquantModérée

    Antihypertensives: Possible additive hypotensive effects. (notice Trinitrine, Interactions médicamenteuses)

  • PrazosinealphabloquantModérée

    Antihypertensives: Possible additive hypotensive effects. (notice Trinitrine, Interactions médicamenteuses)

  • Prilocaïne et adrénalineanesthésique localModérée

    …concurrently exposed to the following drugs, which could include other local anesthetics: EXAMPLES OF DRUGS ASSOCIATED WITH METHEMOGLOBINEMIA: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic… (notice Prilocaïne et adrénaline, Interactions médicamenteuses)

  • PropranololbêtabloquantModérée

    Antihypertensives: Possible additive hypotensive effects. (notice Trinitrine, Interactions médicamenteuses)

  • Quinaprilinhibiteur de l'enzyme de conversion (IEC)Modérée

    Antihypertensives: Possible additive hypotensive effects. (notice Trinitrine, Interactions médicamenteuses)

  • Quinapril et hydrochlorothiazideinhibiteur de l'enzyme de conversion (IEC)Modérée

    Antihypertensives: Possible additive hypotensive effects. (notice Trinitrine, Interactions médicamenteuses)

  • Ramiprilinhibiteur de l'enzyme de conversion (IEC)Modérée

    Antihypertensives: Possible additive hypotensive effects. (notice Trinitrine, Interactions médicamenteuses)

  • Ropivacaïneanesthésique localModérée

    …which could include other local anesthetics [see Warnings and Precautions ( 5.4 )] : Examples of Drugs Associated with Methemoglobinemia Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic… (notice Ropivacaïne, Interactions médicamenteuses)

  • Sacubitril et valsartanantagoniste des récepteurs de l'angiotensine II (ARA II)Modérée

    Antihypertensives: Possible additive hypotensive effects. (notice Trinitrine, Interactions médicamenteuses)

  • SotalolbêtabloquantModérée

    Antihypertensives Patients receiving antihypertensive drugs, beta-adrenergic blockers, and nitrates should be observed for possible additive hypotensive effects. (notice Trinitrine, Interactions médicamenteuses)

  • Spironolactoneantagoniste de l'aldostéroneModérée

    Antihypertensives: Possible additive hypotensive effects. (notice Trinitrine, Interactions médicamenteuses)

  • Spironolactone et hydrochlorothiazideantagoniste de l'aldostéroneModérée

    Antihypertensives: Possible additive hypotensive effects. (notice Trinitrine, Interactions médicamenteuses)

  • Telmisartanantagoniste des récepteurs de l'angiotensine II (ARA II)Modérée

    Antihypertensives: Possible additive hypotensive effects. (notice Trinitrine, Interactions médicamenteuses)

  • Telmisartan et amlodipineantagoniste des récepteurs de l'angiotensine II (ARA II)Modérée

    Antihypertensives: Possible additive hypotensive effects. (notice Trinitrine, Interactions médicamenteuses)

  • Telmisartan et hydrochlorothiazideantagoniste des récepteurs de l'angiotensine II (ARA II)Modérée

    Antihypertensives: Possible additive hypotensive effects. (notice Trinitrine, Interactions médicamenteuses)

  • TérazosinealphabloquantModérée

    Antihypertensives: Possible additive hypotensive effects. (notice Trinitrine, Interactions médicamenteuses)

  • TimololbêtabloquantModérée

    Antihypertensives Patients receiving antihypertensive drugs, beta-adrenergic blockers, and nitrates should be observed for possible additive hypotensive effects. (notice Trinitrine, Interactions médicamenteuses)

  • TizanidinemyorelaxantModérée

    Antihypertensives: Possible additive hypotensive effects. (notice Trinitrine, Interactions médicamenteuses)

  • Torasémidediurétique de l'anseModérée

    Antihypertensives: Possible additive hypotensive effects. (notice Trinitrine, Interactions médicamenteuses)

  • Trandolaprilinhibiteur de l'enzyme de conversion (IEC)Modérée

    Antihypertensives: Possible additive hypotensive effects. (notice Trinitrine, Interactions médicamenteuses)

  • Triamtérènediurétique épargneur de potassiumModérée

    Antihypertensives: Possible additive hypotensive effects. (notice Trinitrine, Interactions médicamenteuses)

  • Triamtérène et hydrochlorothiazidediurétique épargneur de potassiumModérée

    Antihypertensives: Possible additive hypotensive effects. (notice Trinitrine, Interactions médicamenteuses)

  • Valsartanantagoniste des récepteurs de l'angiotensine II (ARA II)Modérée

    Antihypertensives: Possible additive hypotensive effects. (notice Trinitrine, Interactions médicamenteuses)

  • Valsartan et hydrochlorothiazideantagoniste des récepteurs de l'angiotensine II (ARA II)Modérée

    Antihypertensives: Possible additive hypotensive effects. (notice Trinitrine, Interactions médicamenteuses)

  • Vérapamilinhibiteur calciqueModérée

    Antihypertensives: Possible additive hypotensive effects. (notice Trinitrine, Interactions médicamenteuses)

Mentions mineures (7)

  • AdrénalinesympathomimétiqueMineure

    Drugs antagonizing pressor effects of epinephrine α-blockers, such as phentolamine Vasodilators, such as nitrates Diuretics Antihypertensives Ergot alkaloids Drugs potentiating pressor effects of epinephrine • Sympathomimetics • β-blockers, such as propranolol • Tricyclic anti-depressants • Monoamine oxidase (MAO) inhibitors • Catechol-O-methyl transferase (COMT)… (notice Adrénaline, Interactions médicamenteuses)

  • Dutastéride et tamsulosineinhibiteur de la 5-alpha-réductaseMineure

    Alpha-adrenergic antagonists and PDE-5 inhibitors are both vasodilators that can lower blood pressure. (notice Dutastéride et tamsulosine, Mises en garde et précautions)

  • Finastérideinhibiteur de la 5-alpha-réductaseMineure

    …acetylsalicylic acid, α-blockers, angiotensin-converting enzyme (ACE) inhibitors, analgesics, anti-convulsants, beta-adrenergic blocking agents, diuretics, calcium channel blockers, cardiac nitrates, HMG-CoA reductase inhibitors, nonsteroidal anti-inflammatory drugs (NSAIDs), benzodiazepines, H 2 antagonists and quinolone anti-infectives without evidence of clinically… (notice Finastéride, Interactions médicamenteuses)

  • MéthohexitalbarbituriqueMineure

    Post injury arterial injection of vasodilators and/or arterial infusion of parenteral fluids are generally regarded to be of no value in altering outcome. (notice Méthohexital, Mises en garde)

  • Milrinoneinhibiteur de la PDE3Mineure

    …been observed in limited experience with patients in whom milrinone was used concurrently with the following drugs: digitalis glycosides; lidocaine, quinidine; hydralazine, prazosin; isosorbide dinitrate, nitroglycerin; chlorthalidone, furosemide, hydrochlorothiazide, spironolactone; captopril; heparin, warfarin, diazepam, insulin; and potassium supplements. (notice Milrinone, Interactions médicamenteuses)

  • SilodosinealphabloquantMineure

    Alpha-adrenergic blockers and PDE5 inhibitors are both vasodilators that can lower blood pressure. (notice Silodosine, Mises en garde et précautions)

  • TamsulosinealphabloquantMineure

    Alpha-adrenergic blockers and PDE5 inhibitors are both vasodilators that can lower blood pressure. (notice Tamsulosine, Mises en garde et précautions)

Vérifiez Trinitrine avec tout ce que vous prenez. Ajoutez votre liste complète ; toutes les paires sont vérifiées en une fois.

Ouvrir dans le vérificateur

Ceci n'est pas un avis médical. Le niveau de gravité reflète la formulation de la notice, pas votre situation. Une alerte « majeure » peut être courante sous surveillance et une alerte « mineure » peut compter à forte dose. Demandez conseil à un pharmacien.